Theme: Targeting Cancer Metabolism to Improve Radiotherapy

Radiotherapy 2019

Radiotherapy 2019

Conference Series LLC Ltd is overwhelmed to welcome all the interested participants to its International Conference on Global Radiation Therapy & Targeted Tumours during April 22-23, 2019 at Vancouver, Canada.

The conference will be organized around the theme: Targeting Cancer Metabolism to Improve Radiotherapy

Dates: April 22-23, 2019

Venue: Vancouver, Canada

Radiation Therapy 2019 is an event that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas communicate and discuss research findings on new advancements in all kinds of available cancer therapies worldwide. Radiation Therapy 2019 aims to focus on the latest developments and advances in Molecular Targets and Cancer Therapeutics Frontiers in Cancer Prevention Research, Cancer Health Disparities, and Frontiers in Basic Cancer Research. This International Congress is going to be the largest and most promising international conference that specifically focuses on the Radiation therapy by bringing all Renowned Radiation Oncologists under one roof. This is a two day multidisciplinary meeting covering all aspects of Cancer Therapies and Radiation Oncology, including clinical service delivery, management, informatics and research.

 

Conference Series LLC Ltd which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

Conference Series LLC Ltd  has an enhanced and highlighted features of scientific partnerships and alliances with development agencies, Institutes, leading research organizations, non-government organizations, and other entities to promote the development-oriented research  across the world through live streaming, B2B and Scientific Meetings. Conference Series LLC Ltd initiated the 'Young Scientist awards’ to the enterprising young science researchers and scholars across the globe.

 

Radiation Therapy

Radiation therapy (also called radiotherapy) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumours. Doctors who specialize in treating cancer with radiation (radiation oncologists) use radiation therapy to treat a wide variety of cancers. Radiation therapy uses carefully targeted and regulated doses of high-energy radiation to kill cancer cells. Radiation kills cancer cells by damaging the chromosomes and DNA so that the cells can no longer divide and the tumor can't grow. The discussion extends to all available Cancer Therapies like Surgical Therapy, Chemotherapy, Adjuvant Therapy, Neoadjuvant Therapy, Immunotherapy, Hormonal Therapy, Proton Beam Therapy, Phototherapy, Stem Cell Therapy and Alternative Medicine. Radiation therapy uses highly advanced technology to deliver targeted beams of radiation to kill cancer cells.

  • Image guided radiotherapy
  • Adaptive radiotherapy
  • Brachytherapy
  • Stereotactic body radiotherapy
  • Intensity-modulated radiotherapy

Chemotherapy

This treatment method utilizes special drugs that are designed to target and kills cells that divide rapidly. Since rapid division is a core characteristic of cancer cells, the drugs are effective at killing them off. Also, these drugs work through your whole body, not just a specific part, so they can more effectively prevent the cancer cells from spreading to other parts of the body. Unfortunately, there are other cells in the body that naturally divide rapidly, such as those in our hair follicles and digestive systems, which is why chemotherapy typically has side effects of hair loss and digestive issues during treatment. Despite these side effects, it is important to remember that the medication is working to kill off the cancer cells.

  • Chemoembolization
  • Intra-arterial chemotherapy
  • Intraperitoneal chemotherapy
  • Intrathecal chemotherapy

Immunotherapy

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system. Immunotherapy is a type of biological therapy. Biological therapy is a type of treatment that uses substances made from living organisms to treat cancer.

  • Checkpoint inhibitors
  • Adoptive cell transfer
  • Monoclonal antibodies
  • Treatment vaccines

Hormone Therapy

Hormone therapy is a cancer treatment that slows or stops the growth of cancer that uses hormones to grow. Hormone therapy is also called hormonal therapy, hormone treatment, or endocrine therapy.

  • Hormone replacement therapy (HRT)
  • Menopausal hormone therapy (MHT)
  • Androgen replacement therapy (ART)
  • Transgender hormone therapy

Stem Cell Transplant

Stem cell transplantation is a procedure that replaces unhealthy blood-forming cells with healthy cells. Stem cell transplantation, sometimes referred to as bone marrow transplant, allows doctors to give large doses of chemotherapy or radiation therapy to increase the chance of eliminating blood cancer in the marrow and then restoring normal blood cell production. The basis for stem cell transplantation is that blood cells (red cells, white cells and platelets) and immune cells (lymphocytes) arise from the stem cells, which are present in marrow, peripheral blood and cord blood. Intense chemotherapy or radiation therapy kills the patient's stem cells. This stops the stem cells from making enough blood and immune cells.

  • Autologous transplant: AUTO transplant
  • Allogeneic transplantation: ALLO transplant

Precision Medicine

Precision medicine is an approach to patient care that allows doctors to select treatments that are most likely to help patients based on a genetic understanding of their disease. This may also be called personalized medicine. According to the Precision Medicine Initiative, precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people.

  • Artificial intelligence in Precision Medicine
  • Precision Medicine Initiative

Image guided radiotherapy

Image-guided radiation therapy (IGRT) is the use of imaging during radiation therapy to improve the precision and accuracy of treatment delivery. IGRT is used to treat tumors in areas of the body that move, such as the lungs. Radiation therapy machines are equipped with imaging technology to allow your doctor to image the tumor before and during treatment. By comparing these images to the reference images taken during simulation, the patient's position and/or the radiation beams may be adjusted to more precisely target the radiation dose to the tumor. To help align and target the radiation equipment, some IGRT procedures may use fiducial markers, ultrasound, MRI, x-ray images of bone structure, CT scan, 3-D body surface mapping, electromagnetic transponders or colored ink tattoos on the skin.

Adaptive radiotherapy

The adaptive radiotherapy technique aims to customize each patient's treatment plan to patient-specific variation by evaluating and characterizing the systematic and random variations through image feedback and including them in adaptive planning. Adaptive radiotherapy will become a new treatment standard.

Neuro interventional radiology

Neuro interventional radiology, or neuro IR, is a relatively new field of medicine, in which renowned physicians develop and perfect new techniques to treat stroke, brain tumors, cerebral aneurysm and other life threatening conditions of the central nervous system through endovascular approaches. The neuro interventional radiology physicians perform advanced techniques to diagnose and/or treat the following:

  • Acute Stroke - Ischemic Stroke
  • Acute Stroke - Hemorrhagic Stroke
  • Arteriovenous Malformations (AVMs)
  • Brain Tumors - Pre-Operative Embolization
  • Carotid Artery Disease and Stenosis
  • Dissection of Carotid and Vertebral Arteries
  • Intracranial Atherosclerosis
  • Pulsatile Tinnitus
  • Retinoblastomas

Cancer Biopsy

During a biopsy, a doctor removes a sample of tissue or fluid from the body. A pathologist inspects the cells under a microscope to see if they are cancerous. If the cells are found to be cancerous, a biopsy may help determine whether the cancer began at the site of the biopsy or if it started somewhere else in the body and spread to the biopsy site. Some biopsies are performed endoscopically, others under image guidance, such as ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) in the radiology suite. In some cases, biopsies are performed in the operating suite. This allows your doctor to collect tissue from deep inside the body.

  • Incisional biopsy
  • Excisional biopsy
  • Core needle biopsy
  • Fine needle aspiration (FNA) biopsy
  • Image-guided biopsy
  • Vacuum-assisted biopsy
  • Endoscopic biopsy
  • Laparoscopic biopsy
  • Bone marrow aspiration and biopsy
  • Liquid biopsy

Cancer Drug Resistance & Cancer Vaccine

Cancer drug resistance is a complex phenomenon that is influenced by drug inactivation, drug target alteration, drug efflux, DNA damage repair, cell death inhibition, EMT, inherent cell heterogeneity, epigenetic effects, or any combination of these mechanisms. Cancer progenitor cells are often drug resistant as well. These progenitor cells can persist in patients seemingly in remission, and they are able to remain stationary or migrate to other sites during metastasis. Thus, cancer progenitor cells can cause cancer relapse at the original tumor site or in distant organs. The next step in anticancer therapy development should target the elimination of such cancer progenitor cells.

Vaccines or vaccinations are medicines that help the immune system to recognize and destroy the cancer cells. Most of the cancer vaccine work in a same way to treat the cancer. Cancer treatment vaccines are different from vaccines that work against the viruses. The following types of cancer vaccines are most commonly under investigation throughout the world:

  • Antigen vaccines
  • Whole cell vaccines
  • Dendritic cell vaccines
  • DNA vaccines
  • Anti idiotype vaccines

Positron Emission Tomography and Computed Tomography (PET-CT) Scans

A PET scan may be combined with a CT scan at many cancer treatment centres. However, you may hear your doctor refer to this procedure just as a PET scan. A PET-CT scan is one way to find cancer and learn its stage. Stage is a way to describe where the cancer is, if it has spread, and if it is changing how your organs work. Knowing this helps you and your doctor choose the best treatment. It also helps doctors predict your chance of recovery.

  • Hybrid PET Imaging Systems
  • PET vs. SPECT
  • Short Half-lives of Radiotracers

Biomarkers

A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Cancer biomarkers can be DNA, mRNA, proteins, metabolites, or processes such as apoptosis, angiogenesis or proliferation. The markers are produced either by the tumor itself or by other tissues, in response to the presence of cancer or other associated conditions, such as inflammation. Such biomarkers can be found in a variety of fluids, tissues and cell lines. A number of different types and forms of cancer biomarkers (tumor markers) exist

  • Cancer Biomarker
  • Prognostic biomarker
  • Diagnostic (screening) biomarker
  • Stratification (predictive) biomarker

Cancer Screening, Diagnosis & Prevention

The main goal of cancer screening is to reduce the number of people who die from the disease, or eliminate deaths from cancer altogether. Some cancer screening tests are Colonoscopy, sigmoidoscopy, and high-sensitivity fecal occult blood tests (FOBTs), Low-dose helical computed tomography, Mammography, Pap test and human papillomavirus (HPV) testing. Others Screening tests are Alpha-fetoprotein blood test, Breast MRI, CA-125 test, PSA test, Virtual colonoscopy.

Cancer Prevention and risk-reduction strategies can greatly lower the physical, emotional, and financial burden of cancer and improve the overall health of cancer survivors, including lowering the risk of the cancer coming back or the formation of a second cancer. It is estimated that more than 72% worldwide populations are having cancer, nowadays 30-50% cancers can be prevented. The most common diagnostic tests and procedures that are commonly used in cancer care

  • Barium Enema
  • Biopsy
  • Bone Marrow Aspiration and Biopsy
  • Bone Scan
  • Breast MRI
  • Colonoscopy
  • Computed Tomography (CT) Scan
  • Positron Emission Tomography and Computed Tomography (PET-CT) Scans
  • Magnetic Resonance Imaging (MRI)

Nuclear Medicine

Nuclear medicine imaging procedures are non-invasive and, with the exception of intravenous injections, are usually painless medical tests that help physicians diagnose and evaluate medical conditions. Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material to diagnose and determine the severity of or treat a variety of diseases, including many types of cancers, heart disease, gastrointestinal, endocrine, neurological disorders and other abnormalities within the body.

Nuclear medicine therapies include:

  • Radioactive iodine (I-131) therapy used to treat some causes of hyperthyroidism and thyroid cancer
  • Radioactive antibodies used to treat certain forms of lymphoma
  • Radioactive phosphorus (P-32) used to treat certain blood disorders
  • Radioactive materials used to treat painful tumor metastases to the bones
  • I-131 MIBG used to treat adrenal gland tumors in adults and adrenal gland/nerve tissue tumors in children

Radioimmunotherapy (RIT)

Radio immunotherapy (RIT) is a combination of radiation therapy and immunotherapy used to treat non-Hodgkin B-cell lymphoma and other types of cancer. RIT uses engineered monoclonal antibodies paired with radioactive materials called radiotracers. When injected into the patient's bloodstream, they bind to cancer cells and deliver a high dose of radiation directly to the tumor. In RIT, a monoclonal antibody is paired with a radioactive material, or radiotracer. When injected into the patient's bloodstream, the radiation-linked monoclonal antibody, or agent, travels to and binds to cancer cells, allowing a high dose of radiation to be delivered directly to the tumor.

Proton Therapy

Proton therapy delivers radiation to tumor tissue in a much more confined way than conventional photon therapy thus allowing the radiation oncologist to use a greater dose while still minimizing side effects. Protons are atoms that carry a positive charge. Just as x-rays (also known as photons) are used to treat both benign and malignant tumors, protons beams can be used to irradiate tumors in a similar way. However, protons deliver a dose of radiation in a much more confined way to the tumor tissue than photons. After they enter the body, protons release most of their energy within the tumor region and, unlike photons, deliver only a minimal dose beyond the tumor boundaries.

Medical Imaging

Medical imaging refers to several different technologies that are used to view the human body in order to diagnose, monitor, or treat medical conditions. Each type of technology gives different information about the area of the body being studied or treated, related to possible disease, injury, or the effectiveness of medical treatment.

  • Ultrasound Imaging
  • MRI (Magnetic Resonance Imaging)
  • Pediatric X-ray Imaging
  • Medical X-ray Imaging

Advances in Medical Imaging and Diagnosis

The recent advances in medical imaging have revolutionized the diagnostic accuracy of the medical images. These advances included multi-modal imaging, dynamic imaging, and diagnostic imaging with non-ionizing radiation. Most of these advances included a development of robust, rapid, and reliable instruments, with an emphasis on seamless operation in the clinic.

As techniques like image guided radiation therapy (IGRT) and imaging guided surgery (IGS) are becoming more prevalent in the clinic, the demand for quantitative information extraction is becoming much higher. As modern radiology is moving towards non-invasive procedures, these advances in medical imaging have improved the quality of life and reduced the associated risk with these procedures. At the same time, these advances in medical imaging posed new challenges and this talk will highlight these challenges along with the advances.

Angiogenesis Inhibitors

Angiogenesis inhibitors are drugs that block angiogenesis. These drugs are also called anti-angiogenics. Blocking nutrients and oxygen from a tumor can "starve" it. Angiogenesis inhibitors are unique cancer-fighting agents because they block the growth of blood vessels that support tumor growth rather than blocking the growth of tumor cells themselves. The U.S. Food and Drug Administration (FDA) has approved a number of angiogenesis inhibitors to treat cancer. Approved angiogenesis inhibitors include:

  • Axitinib
  • Bevacizumab
  • Cabozantinib
  • Everolimus
  • Lenalidomide
  • Lenvatinib mesylate
  • Pazopanib
  • Ramucirumab

Tumor Microenvironment

The tumor microenvironment is created by the tumor and dominated by tumor-induced interactions. Although various immune effector cells are recruited to the tumor site, their anti-tumor functions are down regulated, largely in response to tumor-derived signals. A tissue microenvironment of developing tumor is comprised of proliferating tumor cells, the tumor stroma, blood vessels, infiltrating inflammatory cells and a variety of associated tissue cells. It is a unique environment that emerges in the course of tumor progression as a result of its interactions with the host.

Cancer Genomics

Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell proliferation and the evolution of the cancer genome under mutation and selection by the body environment, the immune system and therapeutic interventions. Cancer genomics research also contributes to precision medicine by defining cancer types and subtypes based on their genetics. This molecular taxonomy of cancer can provide patients with a more precise diagnosis, and therefore a more personalized treatment strategy.

Radiopharmaceutical Chemistry

Radiopharmaceuticals or medical radio compounds are groups of pharmaceutical drugs that can be used either for diagnostic or therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radioisotopes emitting penetrating gamma rays are used for diagnostic (imaging) where the radiation has to escape the body before being detected by a specific device (SPECT/PET cameras). Typically, the radiation emitted by isotope used for imaging vanishes completely after 1 day through radioactive decay and normal body excretion. The most common isotopes for imaging are: 99mTc, I-123, I-131, Tl201, In111 and F18.

Market Analysis Report

The global market for radiotherapy is broadly segmented on the basis of location of radiation application, type of cancer and specific technology employed. Based on the severity of the cancer, radiation beam is applied externally, internally or systemically. Radiation beams which are internally applied vary from low dose to high dose therapy based on the requirement. For external application of radiation beam the main technologies available are 3D conformal radiotherapy, adaptive radiation therapy, tomotherapy, image guided and intensity modulated radiation therapy. In gynecological, penile, esophageal and cervical cancers internal radiotherapy finds greater application while external radiotherapy treatments are used in breast, prostate, head, spine, neck, lung and brain cancers. The latest developments in implementation of CT aided intensity modulated radiotherapy and image guided techniques are expected to fuel market growth throughout the forecast period. 

The global radiation oncology market size was valued at USD 5.7 billion in 2016 and is expected to grow at a CAGR of 6.5% over the forecast period. Rising adoption of radiotherapy, technological advancements in radiotherapy, rising prevalence of cancer, and increasing healthcare expenditure are the key contributing factors for lucrative growth of radiation oncology market over the forecast period. Radiotherapy is an effective treatment for many types of cancer. Radiotherapy can also be used in combination with surgery, chemotherapy, or immunotherapy. Rising adoption of radiotherapy is boosting the market growth at a significant rate. Radiotherapy can be used at three levels including primary cancer treatment, adjuvant therapy after chemotherapy or surgery, and as palliative therapy to shrink the size of tumor & suppress the symptoms.

 

U.S. radiation oncology market, by product, 2014 - 2025 (USD Billion)

Technology Insights

3-D CRT technology is anticipated to grow at a lucrative growth rate over 6.5% in the next 8 years. In this technique, the radiation beams form the shape of cancer. This technique is most suitable for tumors, which are irregular in shape and are close to healthy organs. Various medical imaging techniques such as computed tomography, magnetic resonance imaging, and positron emission tomography are utilized to understand the tumor shape & size, which are then conformed in beam through computer program.

Global radiation oncology market, by technology, 2016 (%)

Intensity Modulated Radiotherapy (IMRT) is an advanced type of precision radiotherapy method, which is a next-generation treatment line of the 3-D CRT. IMRT is one of the supreme technology in radiotherapy space vertical as it can conform the radiation volume at complex tumor locations. This method is efficient and poses lesser postoperative complications as the dose can be controlled. Image-Guided Radiation Therapy (IGRT) contributed in technology with around 13.0% share in 2016. In this method, the overall objective is to minimize the exposure to the healthy surrounding tissue. In order to achieve greater accuracy, planning target volumes are calculated considering geographic uncertainties.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date April 22-23, 2019
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View